申请人:NAT INST OF BIOLOGICAL SCIENCES BEIJING
公开号:WO2017152842A1
公开(公告)日:2017-09-14
Compounds that inhibit kinase Lck or Btk, pharmaceutically acceptable salts, hydrides, stereoisomers and pharmaceutical compositions thereof are disclosed.
抑制激酶Lck或Btk的化合物,其药用盐、氢化物、立体异构体以及其药物组合物被披露。